The New England journal of medicine
-
Randomized Controlled Trial
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.
Dostarlimab is an immune-checkpoint inhibitor that targets the programmed cell death 1 receptor. The combination of chemotherapy and immunotherapy may have synergistic effects in the treatment of endometrial cancer. ⋯ Dostarlimab plus carboplatin-paclitaxel significantly increased progression-free survival among patients with primary advanced or recurrent endometrial cancer, with a substantial benefit in the dMMR-MSI-H population. (Funded by GSK; RUBY ClinicalTrials.gov number, NCT03981796.).
-
Randomized Controlled Trial
Treatment of Gestational Diabetes Mellitus Diagnosed Early in Pregnancy.
Whether treatment of gestational diabetes before 20 weeks' gestation improves maternal and infant health is unclear. ⋯ Immediate treatment of gestational diabetes before 20 weeks' gestation led to a modestly lower incidence of a composite of adverse neonatal outcomes than no immediate treatment; no material differences were observed for pregnancy-related hypertension or neonatal lean body mass. (Funded by the National Health and Medical Research Council and others; TOBOGM Australian New Zealand Clinical Trials Registry number, ACTRN12616000924459.).
-
Randomized Controlled Trial
Transplantation Outcomes with Donor Hearts after Circulatory Death.
Data showing the efficacy and safety of the transplantation of hearts obtained from donors after circulatory death as compared with hearts obtained from donors after brain death are limited. ⋯ In this trial, risk-adjusted survival at 6 months after transplantation with a donor heart that had been reanimated and assessed with the use of extracorporeal nonischemic perfusion after circulatory death was not inferior to that after standard-care transplantation with a donor heart that had been preserved with the use of cold storage after brain death. (Funded by TransMedics; ClinicalTrials.gov number, NCT03831048.).
-
Editorial Comparative Study
Early versus Second-Trimester Screening and Treatment for Diabetes in Pregnancy.